FBXO22 and osteosarcoma: EdU assay data suggested that the overexpression of FBXO22 increased the number of EdU‐positive U2OS, SaOS‐2 and MG63 cells, indicating that the upregulation of FBXO22 promoted the proliferation of osteosarcoma cells (Figure 3C,D).